Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A2 pseudogene 5 (EIF4A2P5) is a pseudogene, meaning it is a nonfunctional segment of DNA that closely resembles the functional EIF4A2 gene, which encodes a protein involved in the initiation of eukaryotic cell translation[5][2][3]. Pseudogenes such as EIF4A2P5 are generally not translated into functional proteins and do not serve as direct therapeutic targets. While most pseudogenes are historically classified as “junk DNA,” emerging evidence suggests some can be transcribed into RNA and play regulatory roles, such as acting as decoys for microRNAs or sources of small interfering RNAs that influence the expression of related protein-coding genes[4][3]. However, specific functional data for EIF4A2P5 are lacking, and there is no evidence for a canonical, direct role in disease or as a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A2 pseudogene 5 (EIF4A2P5).